Tag
This review analyzes a decade-long nationwide study on TB after Allo-HSCT in France, revealing a 60/100,000 incidence rate, high extrapulmonary involvement, and the critical need for screening patients from high-incidence regions.
This nationwide retrospective study in France highlights the rare but severe incidence of tuberculosis (TB) in Allo-HSCT recipients, identifying birth in high-prevalence countries as a primary risk factor and emphasizing the need for target
Phase 3 trial results demonstrate that a daily fixed-dose combination of doravirine and islatravir effectively maintains virological suppression in adults with HIV-1, offering a comparable and safe alternative to standard integrase inhibito
Discover how a parasitic worm quietly invades the human body, evading pain and immune detection, causing millions of infections and thousands of deaths annually, with its spread now threatening new regions amid climate change and travel.
Chikungunya virus, once rare, is making a concerning comeback globally. This article explores its resurgence, clinical impact, misconceptions, and expert-backed strategies to stay protected.
A deep dive into humanity’s ongoing struggle with viruses and microbes—what science reveals, common myths, and how we can best protect ourselves.
Antibiotic resistance is growing worldwide, threatening our ability to treat common infections. Discover the science, misconceptions, and what we can all do to combat superbugs.